Professor H. Phillip Koeffler, Professor, Department of Medicine, National University of Singapore (NUS), Deputy Director (Research), National University Cancer Institute, Singapore (NCIS), Senior Consultant, Department of Haematology-Oncology, NCIS and Senior Principal Investigator, Cancer Science Institute of Singapore, NUS is one of the three renowned clinician scientists who had received the prestigious Singapore Translational Research (STaR) Investigator Awards to conduct research in Singapore. The award, jointly offered by the Ministry of Health (MOH) and The Agency for Science, Technology and Research (A*STAR), provides research and salary funding to the researchers over a period of five years.
The STaR award is an initiative under the Biomedical Sciences Initiatives Phase II. Its objective is to recruit top-notch clinician scientists to carry out medical research, henceforth bringing about better clinical applications and patient outcomes.
The STaR Investigators will help to foster strong collaborations with research groups and institutions within Singapore and globally. More importantly, they will also serve as mentors for the younger researchers.
Professor Koeffler is an international cancer researcher who was from the prestigious Cedars-Sinai Medical Centre, United States of America. The other two STaR awardees this year include a health sciences research expert who is also the Director and Professor of the Health Sciences Research Programme in Duke-NUS Graduate Medical School Singapore and an international cancer researcher from the Van Andel Research Institute (VARI) from the United States of America.
For more information, click here.
|
